Hemispherx Biopharma Inc (NYSE American:HEB)

0.4402
Delayed Data
As of 10:57am ET
 -0.0065 / -1.46%
Today’s Change
0.30
Today|||52-Week Range
0.84
+27.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-16.2M-17.5M-15.2M-7.5M
 
 
 
 
 
Depreciation691.0K1.1M975.0K1.2M
 
 
 
 
 
Total Other Cash Flow1.5M457.0K774.0K-1.1M
 
 
 
 
 
Funds From Operations-14.0M-15.9M-13.5M-7.4M
 
 
 
 
 
Funds From/For Other Operating Expenses2.8M-1.9M2.6M-29.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-16.8M-13.9M-16.1M-7.4M
 
 
 
 
 
 
InvestingDecrease In Investments23.5M3.2M6.8M3.4M
 
 
 
 
 
Capital Expenditures-898.0K-504.0K-240.0K-160.0K
 
 
 
 
 
Other Investing - Uses-71.0K0.000.000.00
 
 
Other Investing - Sources0.002.0K0.00--
 
 
Net Cash Flow Investing22.3M2.5M6.4M2.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings0.000.00--14.0K
 
 
Long Term Debt Reduction-7.1M-34.0K-21.0K-1.0K
 
 
 
 
 
Net Proceeds Stock Sale249.0K12.8M9.7M4.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-6.8M12.8M9.7M4.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-1.4M1.4M-41.0K293.0K